NCOA4 and prostate carcinoma: Furthermore, as PCa is hormonally driven, the crosstalk between AR and VDR in prostate cancer was previously investigated, reporting that AR activation inhibits VDR-mediated transcription through the activity of different coregulatory proteins such as prohibitin, ARA70, or ZNF366 [70–72].